These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 1692940

  • 1. Differential effects of the antianginal drug nicorandil on canine arteries and veins.
    Morrison KJ, Flavahan NA, Vanhoutte PM.
    J Cardiovasc Pharmacol; 1990 May; 15(5):791-8. PubMed ID: 1692940
    [Abstract] [Full Text] [Related]

  • 2. Pharmacology of pentoxifylline in isolated canine arteries and veins.
    Hoeffner U, Aarhus LL, Katusic ZS, Vanhoutte PM.
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):899-907. PubMed ID: 2481780
    [Abstract] [Full Text] [Related]

  • 3. Effects of basal and acetylcholine-induced release of endothelium-derived relaxing factor on contraction to alpha-adrenoceptor agonists in a rabbit artery and corresponding veins.
    McGrath JC, Monaghan S, Templeton AG, Wilson VG.
    Br J Pharmacol; 1990 Jan; 99(1):77-86. PubMed ID: 1970495
    [Abstract] [Full Text] [Related]

  • 4. Effect of cooling on alpha-1 and alpha-2 adrenergic responses in canine saphenous and femoral veins.
    Flavahan NA, Vanhoutte PM.
    J Pharmacol Exp Ther; 1986 Jul; 238(1):139-47. PubMed ID: 3014112
    [Abstract] [Full Text] [Related]

  • 5. [Effects of nicorandil, a potassium agonist, on the human umbilical artery. Role of the vascular endothelium].
    Tiritilli A, Levy P, Haïat R.
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1095-9. PubMed ID: 8572852
    [Abstract] [Full Text] [Related]

  • 6. Pharmacology of bucindolol in isolated canine vascular smooth muscle.
    Rimele TJ, Aarhus LL, Lorenz RR, Rooke TW, Vanhoutte PM.
    J Pharmacol Exp Ther; 1984 Nov; 231(2):317-25. PubMed ID: 6149305
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The contribution of guanylate cyclase stimulation and K+ channel opening to nicorandil-induced vasorelaxation depends on the conduit vessel and on the nature of the spasmogen.
    Magnon M, Durand I, Cavero I.
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1411-8. PubMed ID: 7908056
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
    Kemp BK, Cocks TM.
    Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Uneven distribution of postjunctional alpha 1-and alpha 2-like adrenoceptors in canine arterial and venous smooth muscle.
    De Mey J, Vanhoutte PM.
    Circ Res; 1981 Jun; 48(6 Pt 1):875-84. PubMed ID: 6261986
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mechanisms of action of eperisone on isolated dog saphenous arteries and veins.
    Inoue S, Bian K, Okamura T, Okunishi H, Toda N.
    Jpn J Pharmacol; 1989 Jul; 50(3):271-82. PubMed ID: 2761129
    [Abstract] [Full Text] [Related]

  • 18. The group at C2 of N-ethylnicotinamide determines the vasodilator potencies and mechanisms of action of nicorandil and its congeners in canine coronary arteries.
    Satoh K, Yamada H, Yoneyama F, Taira N.
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Nov; 344(5):589-95. PubMed ID: 1839805
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.